Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Evaluation of treatment outcome in 175 patients with Hodgkin lymphoma aged 60 years or over: the SHIELD study

Stephen J. Proctor, Jennifer Wilkinson, Gail Jones, Gillian C. Watson, Helen H. Lucraft, Tryfonia Mainou-Fowler, Dominic Culligan, Michael J. Galloway, Katrina M. Wood, Richard J. Q. McNally, Peter W. James, John R. Goodlad

Blood (2012) 119 (25): 6005–6015.

https://doi.org/10.1182/blood-2011-12-396556

Published: 2012

Includes: Supplemental data

Journal Articles

Response: Age- and sex-adjusted incidence rates of adults with acute lymphoblastic leukemia (ALL) in the northern part of England

Anthony V. Moorman, Lucy Chilton, Jennifer Wilkinson, Hannah M. Ensor, Nick Bown, Stephen J. Proctor

Blood (2010) 116 (6): 1012.

https://doi.org/10.1182/blood-2010-04-278895

Published: 2010

Journal Articles

A population-based cytogenetic study of adults with acute lymphoblastic leukemia

Anthony V. Moorman, Lucy Chilton, Jennifer Wilkinson, Hannah M. Ensor, Nick Bown, Stephen J. Proctor

Blood (2010) 115 (2): 206–214.

https://doi.org/10.1182/blood-2009-07-232124

Published: 2010

Journal Articles

A Novel Bayesian Prognostic Index for Diffuse Large B-Cell Lymphoma: A New Powerful Tool for Prediction of Outcome.

Michal Sieniawski, MD, Malcolm Farrow, Xiao Zhao, Jennifer Wilkinson, Tryfonia Mainou-Fowler, Jo White, John MacIntyre, Stephen J. Proctor

Blood (2009) 114 (22): 1666.

https://doi.org/10.1182/blood.V114.22.1666.1666

Published: 2009

Journal Articles

Duration of First Remission in Diffuse Large B-Cell Lymphoma (DLBCL) Define Groups of Patients with Different Overall Survival Which Cannot Be Entirely Distinguished by Clinical Features or IPI at Diagnosis: a Prospective Population Based Study of the Scotland and Newcastle Lymphoma Group

Michal Sieniawski, Jennifer Wilkinson, Dominic Culligan, John Davies, John Goodlad, Ruth Jarrett, Anne L Lennard, Helen Lucraft, Tryfonia Mainou-Fowler, Pam McKay, Fiona Scott, Sudhir Tauro, Jo White, Stephen J Proctor

Blood (2008) 112 (11): 2604.

https://doi.org/10.1182/blood.V112.11.2604.2604

Published: 2008

NARROW

Evaluation of treatment outcome in 175 patients with Hodgkin lymphoma aged 60 years or over: the SHIELD study

Response: Age- and sex-adjusted incidence rates of adults with acute lymphoblastic leukemia (ALL) in the northern part of England

A population-based cytogenetic study of adults with acute lymphoblastic leukemia

A Novel Bayesian Prognostic Index for Diffuse Large B-Cell Lymphoma: A New Powerful Tool for Prediction of Outcome.

Duration of First Remission in Diffuse Large B-Cell Lymphoma (DLBCL) Define Groups of Patients with Different Overall Survival Which Cannot Be Entirely Distinguished by Clinical Features or IPI at Diagnosis: a Prospective Population Based Study of the Scotland and Newcastle Lymphoma Group

Email alerts

ASH Publications

American Society of Hematology

Evaluation of treatment outcome in 175 patients with Hodgkin lymphoma aged 60 years or over: the SHIELD study

Response: Age- and sex-adjusted incidence rates of adults with acute lymphoblastic leukemia (ALL) in the northern part of England

A population-based cytogenetic study of adults with acute lymphoblastic leukemia

A Novel Bayesian Prognostic Index for Diffuse Large B-Cell Lymphoma: A New Powerful Tool for Prediction of Outcome.

Duration of First Remission in Diffuse Large B-Cell Lymphoma (DLBCL) Define Groups of Patients with Different Overall Survival Which Cannot Be Entirely Distinguished by Clinical Features or IPI at Diagnosis: a Prospective Population Based Study of the Scotland and Newcastle Lymphoma Group

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only